Arcutis to Report Fourth Quarter and Full Year 2025 Financial Results and Present at Upcoming Investor Conference

Core Insights - Arcutis Biotherapeutics, Inc. will report its fourth quarter and full year 2025 financial results on February 25, 2026, after U.S. markets close, and will host a conference call at 4:30 p.m. ET on the same day [1] - The company will also participate in the Guggenheim Emerging Outlook: Biotech Summit on February 11, 2026, at 11:30 a.m. ET [2] Company Overview - Arcutis Biotherapeutics is a commercial-stage medical dermatology company focused on innovations for immune-mediated dermatological diseases, with a portfolio of advanced targeted topicals approved for three major inflammatory skin diseases [3] - The company utilizes a unique dermatology development platform and expertise to create differentiated therapies targeting biologically validated targets, resulting in a robust pipeline for various inflammatory dermatological conditions [3]